Reza Mehzad, MD
Clinical Cardiac Electrophysiology · Fairfield, OHNPI 1265468748
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,915 of the $39,655 with a category attached, or 62.8%. Johnson & Johnson accounts for 61.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $13,817 and has fallen 79.0% since, to $2,900 in 2025.
Across 188 payments — averaging $210.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$24K
- Medtronic$8K
- Biosense Webster, Inc.$4K
- Boston Scientific$2K
- Abbott$367
- Bardy Diagnostics, Inc.$320
- plus $1K from 18 others
Across 32 payments — averaging $199.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$6K
What the payments were for
- Consulting fees$4,82512%
- Speaking & faculty fees$24,91563%
- Travel & lodging$2,8697%
- Food & beverage$7,04618%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 34 | $24,464 |
| Medtronic | 33 | $7,968 |
| Biosense Webster, Inc. | 26 | $3,516 |
| Boston Scientific | 35 | $1,581 |
| Abbott | 14 | $367 |
| Bardy Diagnostics, Inc. | 5 | $320 |
| Edwards Lifesciences | 3 | $258 |
| Atricure, Inc. | 4 | $257 |
| Philips North America LLC | 2 | $162 |
| Biotronik Inc. | 2 | $153 |
| ZOLL Respicardia, Inc. | 1 | $120 |
| Amgen | 7 | $101 |
| Novartis | 5 | $88 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $86 |
| Avinger Inc. | 1 | $33 |
| Abiomed | 1 | $27 |
| Convatec Inc. | 1 | $26 |
| Stryker | 1 | $25 |
| AstraZeneca | 2 | $24 |
| Cardiva Medical, Inc. | 1 | $21 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Merck | 1 | $14 |
| Terumo Medical Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$23,999
- EVERA MRI XT DR SURESCAN$880
- Carto 3$671
- WATCHMAN Access System$378
- Watchman$372
- Carnation Ambulatory Monitor$270
- COBALT DR MRI SURESCAN$244
- SAPIEN 3 Ultra RESILIA$199
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$168
- ARCTIC FRONT ADVANCE$159
- Acticor 7 VR-T DX$139
- (9520) IGT Devices Undivided$124
- remede System$120
- AVEIR$115
- OCTARAY MAPPING CATHETER$113
- Carto 3 System$102
- EMBLEM MRI S-ICD$101
How this compares
$39,655 in reported general payments places this provider in the 75th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 180 | $187,288 |
| XareltoRivaroxaban | 55 | $81,452 |
| JardianceEmpagliflozin | 13 | $17,627 |
| Metoprolol Succinate | 152 | $1,936 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 90 | $1,739 |
| Warfarin Sodium | 123 | $1,206 |
| Amiodarone Hcl | 74 | $814 |
| Flecainide Acetate | 15 | $598 |
| Pantoprazole Sodium | 34 | $284 |
| Carvedilol | 26 | $244 |
| JantovenWarfarin Sodium | 16 | $109 |
| ClopidogrelClopidogrel Bisulfate | 18 | $106 |
| Furosemide | 15 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $24,464 | $81,45255 claims |
| Boehringer IngelheimJardiance | $16 | $17,62713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Fairfield
- Anish AminColumbus$1.1M
- Walid SalibaCleveland$511K
- Mohamed KanjBeachwood$442K
- John HummelColumbus$275K
- Bruce WilkoffCleveland$213K
- Alexandru CosteaCincinnati$188K
- Auroa BadinColumbus$188K
- Gaurang GandhiCincinnati$179K
- Ralph AugostiniColumbus$174K
- Dina SparanoMayfield Heights$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.